Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

Nasdaq de-lists Altamira shares

Summary by The Royal Gazette
The common shares of Altamira Therapeutics Ltd, the Bermudian-headquartered biotechnology company, have been de-listed from Nasdaq for failure to comply with the exchange’s rule that listed securities...
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)